Alirocumab Subcutaneously as Monotherapy vs EzetimibeAlirocumab Subcutaneously as Monotherapy vs Ezetimibe

Will a bi-weekly injection be what saves the day for patients with hypercholesterolemia? Future Cardiology

Source: Medscape Today Headlines - March 5, 2015 Category: Consumer Health News Tags: Cardiology Journal Article Source Type: news